Your browser doesn't support javascript.
loading
Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 1-Defining populations at risk.
deLaforcade, Armelle; Bacek, Lenore; Blais, Marie-Claude; Goggs, Robert; Lynch, Alex; Rozanski, Elizabeth.
Afiliação
  • deLaforcade A; Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA.
  • Bacek L; Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL.
  • Blais MC; Department of Clinical Sciences, University of Montreal, Saint-Hyacinthe, QC, Canada.
  • Goggs R; Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY.
  • Lynch A; Department of Clinical Sciences, NC State College of Veterinary Medicine, Raleigh, NC.
  • Rozanski E; Department of Clinical Sciences, Cummings School of Veterinary Medicine at Tufts University, North Grafton, MA.
J Vet Emerg Crit Care (San Antonio) ; 29(1): 37-48, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30654424
OBJECTIVES: Thrombosis is a well-recognized phenomenon in dogs and cats with a significant impact on morbidity and mortality. Despite growing awareness of thrombosis and increased use of antithrombotic therapy, there is little information in the veterinary literature to guide the use of anticoagulant and antiplatelet medications. The goal of Domain 1 was to explore the association between disease and thrombosis in a number of conditions identified as potential risk factors in the current veterinary literature, to provide the basis for prescribing recommendations. DESIGN: A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. Revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated included immune-mediated hemolytic anemia, protein-losing nephropathy, pancreatitis, glucocorticoid therapy, hyperadrenocorticism, neoplasia, sepsis, cerebrovascular disease, and cardiac disease. SETTINGS: Academic and referral veterinary medical centers. RESULTS: Of the diseases evaluated, a high risk for thrombosis was defined as dogs with immune-mediated hemolytic anemia or protein-losing nephropathy, cats with cardiomyopathy and associated risk factors, or dogs/cats with >1 disease or risk factor for thrombosis. Low or moderate risk for thrombosis was defined as dogs or cats with a single risk factor or disease, or dogs or cats with known risk factor conditions that are likely to resolve in days to weeks following treatment. CONCLUSIONS: Documented disease associations with thrombosis provide the basis for recommendations on prescribing provided in subsequent domains. Numerous knowledge gaps were identified that represent opportunities for future study.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Medicina Veterinária / Doenças do Gato / Doenças do Cão / Fibrinolíticos Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Animals País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombose / Medicina Veterinária / Doenças do Gato / Doenças do Cão / Fibrinolíticos Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Animals País como assunto: America do norte Idioma: En Ano de publicação: 2019 Tipo de documento: Article